Antiplatelet — COX-1 Inhibitor
Pregnancy: Avoid in third trimester — premature ductus arteriosus closure; low-dose aspirin used in first/second trimester for pre-eclampsia prevention (different indication)
Aspirin (Orthopaedic VTE Prophylaxis)
Brand names: Aspirin 75 mg, Aspirin 150 mg
Adult dose
Dose: 75–150 mg once daily
Route: Oral
Frequency: Once daily
Max: 150 mg/day
Used for extended VTE prophylaxis following initial LMWH period after total hip and knee arthroplasty. NICE NG89: 75–150 mg daily aspirin is an option for VTE prevention (typically after 1–2 weeks of LMWH). Take with food.
Paediatric dose
Route:
Avoid in children <16 years (Reye's syndrome risk)
Dose adjustments
Renal
Use with caution in renal impairment — NSAIDs reduce renal blood flow; antiplatelet doses are generally safer than analgesic doses
Hepatic
Avoid in severe hepatic impairment — bleeding risk from coagulopathy
Clinical pearls
- EPCAT II trial (NEJM 2018): aspirin non-inferior to rivaroxaban for symptomatic VTE prevention after THR/TKR in low-VTE-risk patients following initial 5-day LMWH — practice-changing for orthopaedics in North America
- NICE NG89 UK guidance: aspirin 75–150 mg is an option for extended prophylaxis following arthroplasty — commonly used as weeks 2–6 after THA (following 14 days LMWH)
- Aspirin-sensitive asthma: all NSAIDs and aspirin are contraindicated — present in 8–20% of adult asthmatics; screen before prescribing
- Pre-operative management: patients on long-term aspirin (cardiac/stroke prevention) — generally continue peri-operatively for THA/TKR; assess bleeding vs thrombotic risk with surgeon and anaesthetist
- Lower cost and oral administration make aspirin attractive for extended prophylaxis vs LMWH injections — patient preference and compliance benefit
Contraindications
- Active peptic ulceration
- Haemophilia and other bleeding disorders
- Aspirin hypersensitivity / aspirin-induced asthma
- Children under 16 years (Reye's syndrome)
- Third trimester of pregnancy
Side effects
- GI irritation, dyspepsia, peptic ulceration
- Bronchospasm in aspirin-sensitive asthma
- Tinnitus (at high analgesic doses — not at antiplatelet doses)
- Increased surgical bleeding (especially if not withheld pre-op)
Interactions
- Ibuprofen — competitive COX-1 blockade; ibuprofen taken 2 hours before aspirin prevents antiplatelet effect
- Warfarin and DOACs — additive bleeding risk
- Uricosurics (probenecid, benzbromarone) — aspirin blocks uricosuric effect
Monitoring
- GI symptoms
- Renal function in at-risk patients
- Platelet function (not routinely required at prophylactic doses)
Reference: BNFc; BNF 90; EPCAT II Trial (NEJM 2018); NICE NG89; AAOS VTE Prevention Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Caprini Score for VTE Risk (2005) · VTE Risk
- DAPT Score · Coronary Artery Disease
- ARC-HBR Criteria for High Bleeding Risk in PCI · Coronary Artery Disease
- PRECISE-DAPT Score for Bleeding on DAPT · Coronary Artery Disease
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
Pathways
- Hip Fracture Management · NICE CG124 / BOA 2020
- Distal Radius Fracture · BOA / NICE
- Ankle Fracture Management · BOA / Lauge-Hansen classification
- Metastatic Spinal Cord Compression · NICE CG75 2020
- Open Fracture Management · BOA/BAPRAS 2017
- OrthoPath: Upper Limb ED Triage · OrthoPath ED Tool — ReviseMRCEM.com